ASMI congratulates Belinda Wood: CEO GMiA
18 December 2014 - The Australian Self Medication Industry (ASMI) today congratulated Belinda Wood on her appointment as the Chief Executive of the Generic Medicines Industry Association (GMiA).
ASMI Executive Director, Dr Deon Schoombie, welcomed Belinda
Wood to her new role saying: "ASMI congratulates Belinda on her
appointment. She has a strong background in the pharmaceutical
sector generally, and GMiA, specifically.
"It is a critically important time for the pharmaceutical sector as it faces a number of challenges as well as new opportunities. Belinda's background places her in an ideal position to play a leadership role in the industry.
"ASMI has built a strong relationship with the GMiA over the
years. We look forward to working with Belinda in the future," said
About ASMI: The Australian Self-Medication Industry (ASMI) is the peak body representing sponsors of non-prescription medicines - over-the-counter (OTC) and complementary medicines. Its members make up 85 per cent of the $4bn self care market. Membership totals 60 companies and ASMI members employ approximately 18,000 people with exports estimated at $1.2 billion annually. ASMI's mission is to promote better health through responsible self care. This means ensuring that safe and effective self care products are readily available to all Australians at a reasonable cost. ASMI works to encourage responsible use by consumers and an increasing role for cost-effective self-medication products as part of the broad national health strategy (www.asmi.com.au).
For more information or to arrange a media interview, please
PR Manager, Australian Self Medication Industry (ASMI)
P: 9923 9410 M:0408 256 381 E: firstname.lastname@example.org